Platforms for Recombinant Therapeutic Glycoprotein Production

Area of Science:

• Biotechnology
• Biopharmaceutical Manufacturing
• Glycobiology

Background:

• The majority of approved biologic drugs are recombinant glycoproteins.
• These therapeutic proteins are vital for treating various diseases.
• Expression system selection critically impacts protein characteristics.

Purpose of the Study:

• To provide an overview of therapeutic recombinant glycoproteins.
• To discuss the various expression platforms used for their production.
• To highlight the significance of glycosylation in protein function.

Main Methods:

• Review of current literature on recombinant glycoprotein production.
• Analysis of different expression systems and their suitability.
• Discussion of glycosylation's role in protein attributes.

Main Results:

• Expression system choice is a critical determinant of protein yield and quality.
• Glycosylation patterns significantly affect pharmacokinetics, biological activity, and immunogenicity.
• Various platforms are available for producing therapeutic glycoproteins.

Conclusions:

• Optimizing expression systems is essential for successful therapeutic glycoprotein development.
• Understanding and controlling glycosylation is paramount for effective biologic drugs.
• This chapter offers insights into production platforms for these vital therapeutics.